Challenges of C1-inhibitor concentrate self-administration.

Abstract

Self-administration of therapy can help hereditary angioedema (HAE) patients regain control of their disease or reduce its impact and improve the quality of their lives. However, data from a self-administration survey, and subsequent discussion at an international HAE expert meeting, identified several barriers to self-administration therapy. These barriers include difficulty in administration technique, availability of nursing resources and the mental capacity of the patient. Encouragingly, international HAE experts identified that once a patient has acquired self-administration skills, they generally retain them in the long-term. As patient uptake increases, it was recommended that follow-up management plans should be established to address any issues from the patient's perspective.

• Authors: H B Boysen, L Bouillet, E Aygören-Pürsün
• Journal: International archives of allergy and immunology (Int Arch Allergy Immunol) Vol. 161 Suppl 1 Pg. 21-5 ( 2013) ISSN: 1423-0097 [Electronic] Switzerland
• PMID: 23689241 (Publication Type: Journal Article)
• Copyright: Copyright © 2013 S. Karger AG, Basel.

Chemical References

• Complement C1 Inhibitor Protein

Topics

• Angioedemas, Hereditary (drug therapy, psychology)
• Complement C1 Inhibitor Protein (administration & dosage)
• Humans
• Quality of Life
• Self Administration (methods, psychology)